Technical Analysis for ANEB - Anebulo Pharmaceuticals, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
B | 3.04 | 0.00% | 0.00 |
ANEB closed unchanged on Wednesday, May 8, 2024, on 3 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: May 9
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
NR7 | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Upper Bollinger Band Walk | Strength | 0.00% | |
Upper Bollinger Band Walk | Strength | 0.00% | |
Gapped Up | Strength | 0.00% | |
Upper Bollinger Band Touch | Strength | 0.00% | |
20 DMA Support | Bullish | 3.05% | |
Upper Bollinger Band Walk | Strength | 3.05% | |
Outside Day | Range Expansion | 3.05% | |
Upper Bollinger Band Touch | Strength | 3.05% |
Alert | Time |
---|---|
Possible NR7 | 1 day ago |
Rose Above Previous Day's High | 1 day ago |
Rose Above Upper Bollinger Band | 1 day ago |
Up 1 ATR | 1 day ago |
Up 5% | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Anebulo is a clinical-stage biotechnology company developing novel solutions for people suffering from cannabinoid overdose and substance addiction. Its lead product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within one hour of administration. Clinical trials completed to date have shown that ANEB-001 is rapidly absorbed, well tolerated and leads to weight loss, an effect that is consistent with central cannabinoid receptor type 1 antagonism.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cannabis Smoking Cannabinoid Addiction Abnormal Psychology
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cannabis Smoking Cannabinoid Addiction Abnormal Psychology
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 4.05 |
52 Week Low | 1.62 |
Average Volume | 5,135 |
200-Day Moving Average | 2.62 |
50-Day Moving Average | 2.76 |
20-Day Moving Average | 2.89 |
10-Day Moving Average | 2.92 |
Average True Range | 0.18 |
RSI (14) | 58.85 |
ADX | 35.01 |
+DI | 30.98 |
-DI | 21.17 |
Chandelier Exit (Long, 3 ATRs) | 2.76 |
Chandelier Exit (Short, 3 ATRs) | 3.14 |
Upper Bollinger Bands | 3.13 |
Lower Bollinger Band | 2.64 |
Percent B (%b) | 0.82 |
BandWidth | 16.84 |
MACD Line | 0.07 |
MACD Signal Line | 0.05 |
MACD Histogram | 0.018 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 3.04 | ||||
Resistance 3 (R3) | 3.04 | 3.04 | 3.04 | ||
Resistance 2 (R2) | 3.04 | 3.04 | 3.04 | 3.04 | |
Resistance 1 (R1) | 3.04 | 3.04 | 3.04 | 3.04 | 3.04 |
Pivot Point | 3.04 | 3.04 | 3.04 | 3.04 | 3.04 |
Support 1 (S1) | 3.04 | 3.04 | 3.04 | 3.04 | 3.04 |
Support 2 (S2) | 3.04 | 3.04 | 3.04 | 3.04 | |
Support 3 (S3) | 3.04 | 3.04 | 3.04 | ||
Support 4 (S4) | 3.04 |